Home/Australian Tariffs/From Netherlands/Pharmaceutical products

Importing Pharmaceutical products from Netherlands into Australia (2026)

No Australia-Netherlands FTA exists so MFN rates apply to all pharmaceutical imports from the Netherlands; the single most critical obligation is confirming each product holds a valid ARTG listing before shipment, as ABF will hold goods at the border pending TGA verification regardless of origin.

No FTA — MFN rates applyHS Chapter 30

Compliance requirements

  • Verify ARTG registration for each imported pharmaceutical line item before booking the shipment.
  • Ensure your TGA Import Licence specifically covers the Netherlands-sourced goods being imported.
  • If importing narcotics or psychotropics, lodge ODC permit applications at least 15 business days before vessel departure.
  • All therapeutic goods for human use must be listed or registered on the Australian Register of Therapeutic Goods (ARTG) before importation — ABF will hold shipments if the ARTG entry cannot be confirmed at the border
  • The importer must hold a current TGA Manufacturing or Import Licence (issued under the Therapeutic Goods Act 1989) — this licence must match the specific goods being imported, and spot audits do occur
  • Narcotic, psychotropic, and certain precursor substances require a permit from the Office of Drug Control (ODC) under the Narcotic Drugs Act before each shipment; permits are shipment-specific so plan lead times of 10–15 business days
  • Biological medicines, vaccines, and any product of animal origin require DAFF biosecurity assessment and may need a Biosecurity Import Permit — cold-chain integrity documentation is also scrutinised at the border for temperature-sensitive biologics
  • Goods exempt from ARTG registration (e.g. certain compounded medicines or personal use exemptions) still require a formal TGA exemption reference to be cited on the import declaration to avoid ABF detention
  • No FTA exists between Australia and Netherlands so MFN (general) tariff rates apply to all imports; a formal Certificate of Origin is not required for preferential purposes but may be requested by the ABF to confirm non-preferential origin for statistical or anti-dumping purposes
  • ACMA regulatory compliance is mandatory for all electrical and electronic goods including telecommunications equipment; suppliers must provide declarations of conformity and relevant test reports prior to import
  • Biosecurity declarations and potential DAFF inspection apply to any goods containing plant material, dairy-derived inputs, or biological reagents, which is particularly relevant for Netherlands agricultural inputs, cut flowers, seeds, and food products
  • Therapeutic goods including pharmaceuticals and medical devices must be registered or listed on the Australian Register of Therapeutic Goods (ARTG) administered by the TGA before importation; Netherlands is a major pharmaceutical exporter and this is a critical compliance step

Key documents required

  • commercial invoice citing ARTG registration or listing number for each product line
  • TGA Import Licence or Manufacturing Licence copy (held by the importer of record)
  • Office of Drug Control (ODC) import permit for controlled substances (Schedule 8 or precursor chemicals)
  • Certificate of Analysis (CoA) and Manufacturer's Certificate of GMP Compliance or equivalent TGA-accepted GMP clearance
  • DAFF Biosecurity Import Permit and cold-chain temperature records for biologics, vaccines, or animal-derived products

Import tip

Lodge your ODC controlled substance import permit application at least three weeks before the vessel or aircraft departs origin — ODC permits cannot be expedited after shipment, and a single missing permit number on the import declaration will result in ABF referral and potential destruction of the consignment.

Calculate the total landed cost for Chapter 30 goods from Netherlands — duty, GST, IPC, and biosecurity included.

Other product categories imported from Netherlands